<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04461730</url>
  </required_header>
  <id_info>
    <org_study_id>38RC19.271</org_study_id>
    <nct_id>NCT04461730</nct_id>
  </id_info>
  <brief_title>Role of Basal Ganglia and Thalamus in Perceptual Consciousness and Metacognition</brief_title>
  <acronym>METACTION</acronym>
  <official_title>Role of Basal Ganglia and Thalamus in Perceptual Consciousness and Metacognition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The term perceptual awareness refers to subjective experience... or the phenomenology
      associated with the processing of a sensory stimulus. The term metacognition refers to our
      ability of introspection, knowledge and control of our own cognitive processes. The objective
      of this research is to establish the contribution of the basal ganglia and thalamus to the
      perceptual awareness and meta-cognition, using deep brain stimulation coupled with
      electroencephalography.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2020</start_date>
  <completion_date type="Anticipated">October 2025</completion_date>
  <primary_completion_date type="Anticipated">October 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Behavioral effect of DBS on confidence</measure>
    <time_frame>by fall 2024</time_frame>
    <description>Confidence in correct and incorrect responses will be compared on and off stimulation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of DBS on EEG markers of confidence</measure>
    <time_frame>by fall 2024</time_frame>
    <description>EEG correlates of confidence in correct and incorrect responses will be compared on and off stimulation</description>
  </secondary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Parkinson Disease</condition>
  <condition>OCD</condition>
  <condition>Dystonia</condition>
  <arm_group>
    <arm_group_label>Parkinson disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>essential tremor</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>dystonia</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>OCD</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>deep brain stimulation</intervention_name>
    <description>Behavioral and electroencephalographic responses will be compared on and off deep brain stimulation</description>
    <arm_group_label>OCD</arm_group_label>
    <arm_group_label>Parkinson disease</arm_group_label>
    <arm_group_label>dystonia</arm_group_label>
    <arm_group_label>essential tremor</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pathologies included will be Parkinson's disease (PD), essential tremor, dystonia, and
        obsessive compulsive disorder (OCD).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Major patient in need of brain stimulation therapy for motor disorders (Parkinson's
             disease, tremor, dystonia) or psychiatric disorders (OCD).

          -  Outpatient or inpatient follow-up

          -  Fluent in French and able to understand the study procedures

          -  informed consent

          -  Patient affiliated to social security

          -  Written agreement to participate in the patient's study

          -  Intellectual abilities compatible with the performance of cognitive or motor tasks

        Exclusion Criteria:

          -  Persons referred to in Articles L1121-5 to L1121-8 of the CSP (pregnant women,
             parturient women, mothers, etc.) who is breastfeeding, person deprived of liberty by
             judicial or administrative decision, person subject to a legal protection measure

          -  Patients in whom transient cessation of stimulation is not tolerated

          -  Subject in period of exclusion from another study

          -  Subject cannot be contacted in case of emergency

          -  Subject under administrative or judicial supervision
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nathan Faivre, PhD</last_name>
    <phone>+33 4 76 82 83 19</phone>
    <email>nathan.faivre@univ-grenoble-alpes.fr</email>
  </overall_contact>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 26, 2020</study_first_submitted>
  <study_first_submitted_qc>July 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2020</study_first_posted>
  <last_update_submitted>July 3, 2020</last_update_submitted>
  <last_update_submitted_qc>July 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>metacognition</keyword>
  <keyword>consciousness</keyword>
  <keyword>deep brain stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Dystonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Experimental paradigms, anonymized behavioral and EEG data and analysis scripts will be made freely available on dedicated platforms (e.g zenodo)</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Data will be shared upon publication of results, for an unlimited duration.</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

